AVE 16.7% 0.3¢ avecho biotechnology limited

Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.